PerkinElmer Stock To Go Ex-dividend Tomorrow (PKI)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- The ex-dividend date for PerkinElmer (NYSE: PKI) is tomorrow, April 17, 2013. Owners of shares as of market close today will be eligible for a dividend of 7 cents per share. At a price of $34.22 as of 9:31 a.m. ET, the dividend yield is 0.8%.

The average volume for PerkinElmer has been one million shares per day over the past 30 days. PerkinElmer has a market cap of $3.96 billion and is part of the health care sector and health services industry. Shares are up 10% year to date as of the close of trading on Monday.

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates in two segments, Human Health and Environmental Health. The company has a P/E ratio of 58.2, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates PerkinElmer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full PerkinElmer Ratings Report.

See our dividend calendar or top-yielding stocks list.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Takes Cautious Approach to M&A

PerkinElmer Medical Imaging Unit Sale Could Be in the Works

Trade-Ideas: PerkinElmer (PKI) Is Today's "Barbarian At The Gate" Stock

Jim Cramer's 'Mad Money' Recap: Short-Term Pain? Try Investing for Long-Term Gain